I
Intercell
Intercell AG, a biotechnology company, engages in the design and development of vaccines for the prevention and treatment of infectious
About Intercell
Based in Amsterdam, Intercell is an electronic music collective and events platform that originated in 2015. Initially starting as a small rave on the city's outskirts, the organization has since grown into an international presence within the electronic music scene. The core of Intercell's business is the curation and broadcasting of electronic music events. These events are held in a variety of locations, from industrial warehouses to iconic venues, with a focus on creating an immersive and intimate experience for the audience. The company's event portfolio includes world premieres, unique collaborations, and performances by both new and established artists.
Beyond physical events, Intercell has expanded its reach by becoming a digital platform. The company utilizes video recordings, live reports, and artist content to broadcast its events and vision to a global audience online. This dual approach of hosting offline experiences while building a worldwide digital presence allows the company to engage with electronic music fans both in-person and remotely.
The business model appears to be centered on ticket sales for its live events and potentially revenue from its digital content and apparel, which is listed on their website. They cater to a global community of electronic music enthusiasts who are looking for curated and high-quality music experiences. By focusing on specific niches within the electronic music spectrum, such as vinyl-only sets and unique back-to-back performances, Intercell has carved out a distinct position in the competitive live music market.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1998
- Headquarters
- Vienna, Austria
- Listing
- IPO 2005
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Developer Tools, Biotechnology, Vaccines, Spinout, Biotech and Pharma, Horizon Europe, DT and LS, science-based
- Client focus
- b2c
- Investment activity
- 2 companies, latest May 2013
- Capital deployed
- —
- Preferred round
- ACQUISITION
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO EQUITYOther financing | Dec 2007 | — | — | Thuja Capital | — |
| IPOOther financing | Feb 2005 | $0 | — | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
| Year | Revenue | Growth |
|---|---|---|
| 2026 | $39M | 0% |
| 2025 | $39M | 0% |
| 2024 | $39M | 0% |
| 2023 | $39M | 0% |
| 2022 | $39M | 0% |
| 2021 | $39M | 0% |
| 2020 | $39M | — |
Growth signals
Latest recorded traffic for Intercell is 430 monthly website visits, up 330% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
ValnevaSaint-Herblain, FranceA biotech company developing and commercializing vaccines for infectious diseases with major unmet needs
$765Mvaluation
IC
Iomai CorporationGaithersburg, United StatesIomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called
$216Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Techno Venture Management
Series B and later5 investors entered at this stage
Star Ventures- GVGlobal Life Science Ventures
Apax Partners
MPM BioImpact
Thuja Capital
Other known investors2 additional known investors
Vienna Research Institute of Molecular Pathology
Technology Pioneers | World Economic Forum
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Intercell on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Intercell’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






